arrow
C

Chrystelle Colas

Institut Curie
H指数:41
被引数:6,586

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: data from the PRED-IdF network

更正:随访、癌症风险和Peutz-Jeghers综合征的死亡率:来自PRED-IdF网络的数据

2026-07-030
OA
Follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: Data from the PRED-IdF network

Peutz-Jeghers综合征的随访、癌症风险和死亡率:PRED-IdF网络的数据

2026-05-130
OAAI
Priority European strategies for sustainable access to high-quality genetic counselling in cancer: A Delphi study

优先考虑欧洲策略,以可持续方式获取癌症领域的高质量遗传咨询:一项德尔菲研究

2026-02-130
OAAI
Genetic background predicts uveal melanoma patients’ outcomes

遗传背景预测葡萄膜黑色素瘤患者的预后

2025-10-100
OAAI
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers

携带胚系DDX41致病性变异的髓系肿瘤风险

2025-10-030
PRE
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)

PTEN错构瘤综合征(PHTS)中第二原发癌的风险

2025-05-240
OAAI
Clinico-pathological Characteristics of Breast Invasive Lobular Carcinoma in non-CDH1 genetic predisposition. Experience from the Institut Curie
2025-03-010
PRE
Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registry
2024-04-011
PRE
Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction

在基于canrik的乳腺癌风险预测中纳入遗传和非遗传危险因素的临床意义

BREAST
IF7.9
2024-02-014
OAAI
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement
BREAST
IF7.9
2024-02-010
OAAI
Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants
2023-12-070
PRE
Impact of molecular profiling and ESCAT classification on patient outcome: The experience of Institut Curie Molecular Tumor Board
2023-12-010
PRE
Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees
2023-09-253
PRE